Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers

被引:22
|
作者
Chuang, Shu-Chun
Hashibe, Mia
Yu, Guo-Pei
Le, Anh D.
Cao, Wei
Hurwitz, Eric L.
Rao, Jian-Yu
Neugut, Alfred I.
Zhang, Zuo-Feng
机构
[1] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] Int Agcy Res Canc, Lyon, France
[4] New York Eye & Ear Infirm, Dept Otolaryngol, Biostat & Epidemiol Serv, New York, NY 10003 USA
[5] Univ So Calif, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Columbia Univ Coll Phys & Surg, Dept Med & Epidemiol, New York, NY 10032 USA
关键词
thyroid cancer; second cancer; radiation therapy;
D O I
10.1016/j.canlet.2005.06.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although radiation is considered a risk factor for thyroid cancer, the potential relationship between radiation therapy and the risk of second primary cancer among patients with first primary thyroid cancer has not been evaluated. We identified 26,639 patients with first primary thyroid cancer in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2000. Information on radiation therapy as well as second primary cancers was recorded in SEER. The proportional hazards model was utilized to estimate adjusted risk ratios (RRs) and their 95% confidence intervals (CIs) to assess the potential association between radiation therapy for thyroid cancer and the risk of second primary cancers. With 270,674.33 person-years of follow-up, 1,896 (7.1%) of the 26,639 patients with first primary thyroid cancer developed second primary cancers. Among the second primaries, 35 occurred in the thyroid. No obvious association was observed between radiation therapy and the overall risk of second primary cancer after ten years of follow-up (RR = 1.07, 95% CI = 0.88-1.30). However, an increased risk was seen for several cancers, including upper digestive system cancers (RR = 1.66, 95% CI = 1.07-2.57) and myeloid malignancies (RR=3.26, 95% CI= 1.39-7.67). Radiation therapy was associated with reduced second cancer risks for thyroid cancer (RR = 0.18, 95% CI = 0.04-0.76). Beam radiation might be important to the digestive system, radioactive implants might be associated with the male genital system, radioisotopes might have an effect on myeloid malignancies, and combined beam radiation with radioactive implants or radioisotopes might be related to the increased risk of respiratory system cancers. This study suggests that radiation therapy for patients with first primary thyroid cancer might be associated with an increased risk of developing a second primary cancer in the upper digestive system and second primary myeloid malignancies. Radiation therapy for adult patients with thyroid cancer might be associated with a reduced risk of second primary thyroid cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [31] Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
    Zheng, Guoqiao
    Sundquist, Kristina
    Sundquist, Jan
    Chen, Tianhui
    Foersti, Asta
    Hemminki, Otto
    Hemminki, Kari
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 52 - 59
  • [32] Proximal location of colorectal cancer is a risk factor for the development of second primary cancers: a population based study
    Gervaz, P
    Huber, O
    Mentha, G
    Morel, P
    GASTROENTEROLOGY, 2003, 124 (04) : A169 - A169
  • [33] Risk factors predicting second primary cancers
    Snow, GB
    Cloos, J
    Bongers, V
    Copper, MP
    Braakhuis, BJM
    HEAD AND NECK CANCER, VOL 4, 1996, : 639 - 644
  • [34] Risk of second primary lung cancer in women after radiotherapy for breast cancer
    Barry, P. N.
    Dragun, A. E.
    BREAST DISEASES, 2015, 26 (03): : 254 - 255
  • [35] Risk of second primary lung cancer in women after radiotherapy for breast cancer
    Grantzau, Trine
    Thomsen, Mette Skovhus
    Vaeth, Michael
    Overgaard, Jens
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 (03) : 366 - 373
  • [36] Risk of second primary lung cancer in women after radiotherapy for breast cancer
    Wong, J. S.
    BREAST DISEASES, 2015, 26 (01): : 78 - 79
  • [37] Second primary malignancy risk after radiotherapy in rectal cancer survivors
    Wang, Ti-Hao
    Liu, Chia-Jen
    Chao, Tze-Fan
    Chen, Tzeng-Ji
    Hu, Yu-Wen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (40) : 4586 - 4595
  • [38] Second primary malignancy risk after radiotherapy in rectal cancer survivors
    Ti-Hao Wang
    Chia-Jen Liu
    Tze-Fan Chao
    Tzeng-Ji Chen
    Yu-Wen Hu
    World Journal of Gastroenterology, 2018, 24 (40) : 4586 - 4595
  • [39] Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer
    Vargas-Ortega, Guadalupe
    Balcazar-Hernandez, Lourdes
    Gonzalez-Virla, Baldomero
    Ramirez-Renteria, Claudia
    Nieto-Guzman, Oriana
    Pamela Garrido-Mendoza, Ana
    Antonio Flores-Maya, Marco
    Mercado, Moises
    Victoria, Mendoza-Zubieta
    JOURNAL OF THYROID RESEARCH, 2018, 2018
  • [40] DEFINITIVE EXTERNAL BEAM RADIOTHERAPY FOR LARYNGEAL CANCER AND RISK FOR SECOND PRIMARY THYROID CARCINOMA: A SEER DATABASE ANALYSIS
    Ahn, P.
    Ahn, A.
    Haigentz, M.
    Smith, R.
    Kalnicki, S.
    Garg, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S252 - S252